New Targets and New Technologies in the Treatment of Parkinson's Disease: A Narrative Review

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Jul 27

PMID 35886651

Authors

Nicola Montemurro

Nelida Aliaga

Pablo Graff

Amanda Escribano

Jafeth Lizana

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease, whose main neuropathological finding is pars compacta degeneration due to the accumulation of Lewy bodies and Lewy neurites, and subsequent dopamine depletion. This leads to an increase in the activity of the subthalamic nucleus (STN) and the internal globus pallidus (GPi). Understanding functional anatomy is the key to understanding and developing new targets and new technologies that could potentially improve motor and non-motor symptoms in PD. Currently, the classical targets are insufficient to improve the entire wide spectrum of symptoms in PD (especially non-dopaminergic ones) and none are free of the side effects which are not only associated with the procedure, but with the targets themselves. The objective of this narrative review is to show new targets in DBS surgery as well as new technologies that are under study and have shown promising results to date. The aim is to give an overview of these new targets, as well as their limitations, and describe the current studies in this research field in order to review ongoing research that will probably become effective and routine treatments for PD in the near future.

Citing Articles

Brain Stimulation Techniques in Research and Clinical Practice: A Comprehensive Review of Applications and Therapeutic Potential in Parkinson's Disease.

Moshayedi A, Mokhtari T, Andani M Brain Sci. 2025; 15(1).

PMID: 39851388 PMC: 11763832. DOI: 10.3390/brainsci15010020.

Functional PET/MRI reveals active inhibition of neuronal activity during optogenetic activation of the nigrostriatal pathway.

Haas S, Bravo F, Ionescu T, Gonzalez-Menendez I, Quintanilla-Martinez L, Dunkel G Sci Adv. 2024; 10(43):eadn2776.

PMID: 39454014 PMC: 11506239. DOI: 10.1126/sciadv.adn2776.

Aquaporin-4 and Parkinson's Disease.

Lapshina K, Ekimova I Int J Mol Sci. 2024; 25(3).

PMID: 38338949 PMC: 10855351. DOI: 10.3390/ijms25031672.

Enhancing microsurgical skills in neurosurgery residents of low-income countries: A comprehensive guide.

Torres C, Mora A, Campero A, Cherian I, Sufianov A, Sanchez E Surg Neurol Int. 2024; 14:437.

PMID: 38213434 PMC: 10783688. DOI: 10.25259/SNI_791_2023.

Learning to Fuse Multiple Brain Functional Networks for Automated Autism Identification.

Zhang C, Ma Y, Qiao L, Zhang L, Liu M Biology (Basel). 2023; 12(7).

PMID: 37508401 PMC: 10376072. DOI: 10.3390/biology12070971.

References

Krause V, Wach C, Sudmeyer M, Ferrea S, Schnitzler A, Pollok B . Cortico-muscular coupling and motor performance are modulated by 20 Hz transcranial alternating current stimulation (tACS) in Parkinson's disease. Front Hum Neurosci. 2014; 7:928. PMC: 3893573. DOI: 10.3389/fnhum.2013.00928. View

Hornykiewicz O . The discovery of dopamine deficiency in the parkinsonian brain. J Neural Transm Suppl. 2006; (70):9-15. DOI: 10.1007/978-3-211-45295-0_3. View

Fregni F, Simon D, Wu A, Pascual-Leone A . Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry. 2005; 76(12):1614-23. PMC: 1739437. DOI: 10.1136/jnnp.2005.069849. View

Tai C, Boraud T, Bezard E, Bioulac B, Gross C, Benazzouz A . Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J. 2003; 17(13):1820-30. DOI: 10.1096/fj.03-0163com. View

Brundin P, Nilsson O, Strecker R, Lindvall O, ASTEDT B, Bjorklund A . Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res. 1986; 65(1):235-40. DOI: 10.1007/BF00243848. View

Oxley T, Opie N, John S, Rind G, Ronayne S, Wheeler T . Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity. Nat Biotechnol. 2016; 34(3):320-7. DOI: 10.1038/nbt.3428. View

Bronstein J, Tagliati M, Alterman R, Lozano A, Volkmann J, Stefani A . Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2010; 68(2):165. PMC: 4523130. DOI: 10.1001/archneurol.2010.260. View

Benabid A, Pollak P, Gervason C, Hoffmann D, Gao D, Hommel M . Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 1991; 337(8738):403-6. DOI: 10.1016/0140-6736(91)91175-t. View

Ni Z, Kim S, Phielipp N, Ghosh S, Udupa K, Gunraj C . Pallidal deep brain stimulation modulates cortical excitability and plasticity. Ann Neurol. 2018; 83(2):352-362. DOI: 10.1002/ana.25156. View

10.

Ghosh B, Zhang C, Smith G . Bridging between transplantation therapy and neurotrophic factors in Parkinson's disease. Front Biosci (Elite Ed). 2014; 6(2):225-35. PMC: 11375561. DOI: 10.2741/E704. View

11.

Vazey E, Aston-Jones G . New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's disease. Brain Res. 2013; 1511:153-63. PMC: 3654066. DOI: 10.1016/j.brainres.2013.01.021. View

12.

Stefani A, Lozano A, Peppe A, Stanzione P, Galati S, Tropepi D . Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain. 2007; 130(Pt 6):1596-607. DOI: 10.1093/brain/awl346. View

13.

Rossi M, Calakos N, Yin H . Spotlight on movement disorders: What optogenetics has to offer. Mov Disord. 2015; 30(5):624-31. PMC: 4397176. DOI: 10.1002/mds.26184. View

14.

Lehericy S, Benali H, Van de Moortele P, Pelegrini-Issac M, Waechter T, Ugurbil K . Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. Proc Natl Acad Sci U S A. 2005; 102(35):12566-71. PMC: 1194910. DOI: 10.1073/pnas.0502762102. View

15.

Hagglund P, Sandstrom L, Blomstedt P, Karlsson F . Voice Tremor in Patients with Essential Tremor: Effects of Deep Brain Stimulation of Caudal Zona Incerta. J Voice. 2015; 30(2):228-33. DOI: 10.1016/j.jvoice.2015.04.003. View

16.

Deisseroth K, Feng G, Majewska A, Miesenbock G, Ting A, Schnitzer M . Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci. 2006; 26(41):10380-6. PMC: 2820367. DOI: 10.1523/JNEUROSCI.3863-06.2006. View

17.

Voorn P, Vanderschuren L, Groenewegen H, Robbins T, Pennartz C . Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 2004; 27(8):468-74. DOI: 10.1016/j.tins.2004.06.006. View

18.

Nandi D, Stein J, Aziz T . Exploration of the role of the upper brainstem in motor control. Stereotact Funct Neurosurg. 2003; 78(3-4):158-67. DOI: 10.1159/000068961. View

19.

Weng S, Li I, Huang Y, Chueh S, Chou T, Huang S . KA-bridged transplantation of mesencephalic tissue and olfactory ensheathing cells in a Parkinsonian rat model. J Tissue Eng Regen Med. 2015; 11(7):2024-2033. DOI: 10.1002/term.2098. View

20.

Peppe A, Gasbarra A, Stefani A, Chiavalon C, Pierantozzi M, Fermi E . Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?. Parkinsonism Relat Disord. 2008; 14(6):501-4. DOI: 10.1016/j.parkreldis.2007.11.005. View